TW200833688A - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders - Google Patents
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersInfo
- Publication number
- TW200833688A TW200833688A TW96150669A TW96150669A TW200833688A TW 200833688 A TW200833688 A TW 200833688A TW 96150669 A TW96150669 A TW 96150669A TW 96150669 A TW96150669 A TW 96150669A TW 200833688 A TW200833688 A TW 200833688A
- Authority
- TW
- Taiwan
- Prior art keywords
- diabetes
- treatment
- receptor agonists
- metabolic disorders
- heterocyclic
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87790306P | 2006-12-28 | 2006-12-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200833688A true TW200833688A (en) | 2008-08-16 |
TWI414523B TWI414523B (en) | 2013-11-11 |
Family
ID=40261614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW96150669A TWI414523B (en) | 2006-12-28 | 2007-12-27 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN101616586B (en) |
AR (1) | AR064702A1 (en) |
CL (1) | CL2007003841A1 (en) |
TW (1) | TWI414523B (en) |
ZA (1) | ZA200904281B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
EP2280704B1 (en) * | 2008-03-31 | 2015-05-13 | Cymabay Therapeutics, Inc. | Oxymethylene aryl compounds and uses thereof |
ES2497566T3 (en) | 2009-10-01 | 2014-09-23 | Cymabay Therapeutics, Inc. | Tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
WO2011134969A1 (en) * | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Ketoheteroarylpiperidine and ketoheteroarylpiperazine derivates as fungicides |
WO2011163090A1 (en) * | 2010-06-23 | 2011-12-29 | Metabolex, Inc. | Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
CN103467398B (en) * | 2013-09-03 | 2015-01-21 | 浙江医药高等专科学校 | Triazole amide compounds, and preparation method and application thereof in resisting diabetes |
US9783533B2 (en) * | 2014-01-06 | 2017-10-10 | Rhizen Pharmaceuticals Sa | Glutaminase inhibitors |
AU2017305392A1 (en) | 2016-08-03 | 2019-02-21 | Cymabay Therapeutics, Inc. | Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions |
CN111072652B (en) * | 2018-10-19 | 2023-05-23 | 暨南大学 | Compounds for the treatment of diabetes and/or related disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1829718A (en) * | 2003-07-14 | 2006-09-06 | 艾尼纳制药公司 | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
WO2005061489A1 (en) * | 2003-12-24 | 2005-07-07 | Prosidion Limited | Heterocyclic derivatives as gpcr receptor agonists |
-
2007
- 2007-12-27 CN CN200780048023.8A patent/CN101616586B/en active Active
- 2007-12-27 CL CL2007003841A patent/CL2007003841A1/en unknown
- 2007-12-27 TW TW96150669A patent/TWI414523B/en active
- 2007-12-27 ZA ZA200904281A patent/ZA200904281B/en unknown
- 2007-12-28 AR ARP070105977 patent/AR064702A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CL2007003841A1 (en) | 2008-03-14 |
TWI414523B (en) | 2013-11-11 |
CN101616586B (en) | 2014-08-13 |
CN101616586A (en) | 2009-12-30 |
ZA200904281B (en) | 2010-08-25 |
AR064702A1 (en) | 2009-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1136943A1 (en) | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | |
MX2011006574A (en) | Gpr120 receptor agonists and uses thereof. | |
TW200833688A (en) | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | |
UA107917C2 (en) | Aryl agonists of gpr120 receptor and its application | |
WO2009014910A3 (en) | N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders | |
MX2010013876A (en) | Aryl gpr119 agonists and uses thereof. | |
WO2010029089A3 (en) | Combination therapy for the treatment of diabetes and related conditions | |
AU2007221366A8 (en) | Oxyntomodulin derivatives | |
UA98629C2 (en) | Compounds and methods for kinase modulation | |
UA97817C2 (en) | Heterocyclic derivatives of 4-(methylsulfonyl)phenyl and use thereof | |
IL193996A0 (en) | Neuromedin u receptor agonists and uses thereof | |
WO2008008887A3 (en) | Gpr119 agonists for treating metabolic disorders | |
WO2007003962A3 (en) | Gpcr agonists | |
WO2007003961A3 (en) | Gpcr agonists | |
WO2007127505A3 (en) | Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system | |
WO2007116229A8 (en) | Heterocyclic gpcr agonists | |
MY162604A (en) | Heterocyclic compounds and uses thereof | |
MX2009007180A (en) | Piperidine gpcr agonists. | |
CO6361917A2 (en) | TREATMENT OF DIABETES IN PATIENTS WITH INSUFFICIENT GLUCEMIC CONTROL TO WEIGHT THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC PHARMACO | |
WO2010123930A3 (en) | Chemosensory receptor ligand-based therapies | |
WO2008008286A3 (en) | Substituted pyrazoles as ghrelin receptor antagonists | |
GB0812642D0 (en) | Compounds | |
MX2007010560A (en) | Roflumilast for the treatment of diabetes mellitus. | |
IL186566A0 (en) | Substituted 2-amin0alkylth10-benzimidaz0les and use thereof for reducing blood sugar levels | |
MA33241B1 (en) | Compounds for the treatment of metabolic disorders |